Indiana Attorney General Todd Rokita filed a new lawsuit against Eli Lilly on December 31, 2025, alleging an insulin price-fixing scheme. The lawsuit claims Lilly conspired with pharmacy benefit managers to inflate insulin sticker prices through secret rebates. Rokita, who attempted amicable resolution for two years, seeks structural changes and damages for affected consumers. Eli Lilly stated it has taken industry-leading steps, including capping patient out-of-pocket costs at $35/month. (Sources: indianapublicradio.org, clintoncountydailynews.com)
Indiana Sues Eli Lilly Over Alleged Insulin Price-Fixing Scheme
LLY
Related News
LLY
Lilly's New Obesity Pill Launches Tomorrow — But Can It Justify a $935 Stock Price in a Price War With Novo?
LLY
Eli Lilly Wins FDA Approval for Foundayo, a Flexible Obesity Pill
LLY
Eli Lilly's $7.8 Billion Sleep-Drug Bet and AI Push: Is the GLP-1 Cash Machine Building a New Empire or Buying Growth It Cannot Organically Create?
LLY
🟢 LLY is trading 3.3% up today amid a broad market rally on de-escalation hopes
LLY